ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
- Jong-Mu Sun†1,
- Ji-Youn Sung†2,
- Se Hoon Park1,
- Ghee Young Kwon2,
- Byong Chang Jeong3,
- Seong Il Seo3,
- Seong Soo Jeon3,
- Hyun Moo Lee3,
- Jisuk Jo4,
- Han Yong Choi3 and
- Ho Yeong Lim1Email author
© Sun et al.; licensee BioMed Central Ltd. 2012
Received: 26 November 2011
Accepted: 22 May 2012
Published: 22 May 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|26 Nov 2011||Submitted||Original manuscript|
|14 Dec 2011||Reviewed||Reviewer Report - Antonio Lopez-Beltran|
|12 Jan 2012||Reviewed||Reviewer Report - Lars Dyrskjot|
|13 Mar 2012||Author responded||Author comments - jong-mu Sun|
|Resubmission - Version 2|
|13 Mar 2012||Submitted||Manuscript version 2|
|31 Mar 2012||Reviewed||Reviewer Report - Antonio Lopez-Beltran|
|10 Apr 2012||Reviewed||Reviewer Report - Lars Dyrskjot|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|22 May 2012||Editorially accepted|
|22 May 2012||Article published||10.1186/1471-2407-12-187|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.